In vivo 31p spectroscopy study of treated and untreated recovery of rat partial brain ischemia

Quantitative 31P NMR was used to follow the time variation of the hypometabolic response to hypoxic partial ischemia in an animal model. The purpose of the study was to establish the value of this repeated spectroscopy operating by means of a surface coil. It aimed at determining whether a therapeutic intervention could influence the transient changes occurring during the insult or early recovery. A pharmacological substance was thus used during a reversible forebrain ischemia, induced by a combination of vascular occlusion and mild hypoxia in two groups of rats. As an available and convenient example, L‐carnitine was chosen. Statistical analysis of the experimental results revealed a significant difference of the P1 and PCr levels between treated and untreated animals.

[1]  F. Plum,et al.  Graded hypoxia-oligemia in rat brain. I. Biochemical alterations and their implications. , 1973, Archives of neurology.

[2]  S. Levine,et al.  Effects of Cerebral Ischemia in Various Strains of Rats.∗ , 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[3]  J. Bremer.  Carnitine--metabolism and functions. , 1983, Physiological reviews.

[4]  T. L. James,et al.  Cerebral metabolite dynamics during temporary complete ischemia in rats monitored by time‐shared 1h and 31p nmr spectroscopy , 1990, Magnetic resonance in medicine.

[5]  G. Garreffa,et al.  Partial cerebral ischemia assessed by "in vivo" 31P NMR spectroscopy in rats. , 1992, Magnetic resonance imaging.

[6]  W. Heiss,et al.  Neurologic deficit, blood flow and biochemical sequelae of reversible focal cerebral ischemia in cats , 1985, Journal of the Neurological Sciences.

[7]  L. Pitts,et al.  High Energy Phosphate Metabolism in Experimental Permanent Focal Cerebral Ischemia: An in vivo 31P Magnetic Resonance Spectroscopy Study , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  J. Mudd,et al.  Carnitine levels in some higher plants , 1969, FEBS letters.

[9]  K. Lundholm,et al.  Concentration of carnitine in human muscle tissue. , 1974, Clinica chimica acta; international journal of clinical chemistry.

[10]  I. Fritz.  CARNITINE AND ITS ROLE IN FATTY ACID METABOLISM. , 1963, Advances in lipid research.

[11]  D. Gadian,et al.  Observation of 1H NMR signals with receiver coils tuned for other nuclides , 1981 .

[12]  G. Fraenkel.  STUDIES ON THE DISTRIBUTION OF VITAMIN BT (CARNITINE) , 1953 .

[13]  D. Gadian,et al.  Mapping of metabolites in whole animals by 31P NMR using surface coils , 1980, Nature.

[14]  J. McIntosh,et al.  Turnover of carnitine by rat tissues. , 1975, The Biochemical journal.

[15]  D. I. Hoult,et al.  Observation of tissue metabolites using 31P nuclear magnetic resonance , 1974, Nature.

[16]  R G Shulman,et al.  Cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy , 1985, Neurology.

[17]  B. Siesjö,et al.  The effect of bilateral carotid artery ligation upon the blood flow and the energy state of the rat brain. , 1972, Acta physiologica Scandinavica.

[18]  R. Shulman,et al.  Combined 1 H and 31P NMR Studies of the Rat Brain in Vivo: Effects of Altered Intracellular pH on Metabolism a , 1987, Annals of the New York Academy of Sciences.